Wangxue Chen Selected Research

Respiratory Tract Infections (Respiratory Tract Infection)

1/2021

Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wangxue Chen Research Topics

Disease

41	Infections 11/2022 - 03/2003
8	Tularemia 05/2008 - 05/2003
4	Pneumonia (Pneumonitis) 01/2021 - 08/2013
4	Inflammation (Inflammations) 01/2019 - 03/2003
3	Neoplasms (Cancer) 08/2021 - 10/2005
3	Respiratory Syncytial Virus Infections 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2021 - 07/2008
3	Human Influenza (Influenza) 10/2020 - 01/2016
2	Communicable Diseases (Infectious Diseases) 08/2021 - 12/2010
2	Sepsis (Septicemia) 01/2019 - 09/2015
2	Bacteremia 05/2016 - 04/2015
2	Bacterial Infections (Bacterial Infection) 09/2009 - 07/2005
2	Hemorrhage 07/2005 - 03/2003
1	Osteoporosis 12/2022
1	Disease Progression 11/2021
1	COVID-19 11/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Bites and Stings (Sting) 08/2021
1	Vaccinia 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Carcinoma (Carcinomatosis) 10/2020
1	Tachypnea 01/2019
1	Airway Obstruction (Choking) 01/2019
1	Experimental Melanoma 01/2018
1	Neuroblastoma 01/2017
1	Cross Infection (Nosocomial Infection) 05/2016
1	Ventilator-Associated Pneumonia 05/2016
1	Reinfection 01/2016
1	Asthma (Bronchial Asthma) 01/2011
1	Healthcare-Associated Pneumonia 10/2009

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 11/2021 - 09/2003
8	CytokinesIBA 01/2020 - 10/2004
8	AerosolsIBA 01/2008 - 05/2003
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2004
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2007
5	AntigensIBA 12/2019 - 08/2004
4	AntibodiesIBA 11/2021 - 10/2010
4	ChemokinesIBA 01/2020 - 05/2008
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2004
3	Hemagglutinins (Hemagglutinin)IBA 10/2020 - 01/2016
3	Toll-Like Receptor 4IBA 09/2015 - 10/2004
3	Oxidoreductases (Dehydrogenase)IBA 05/2011 - 12/2004
3	Interferon-gamma (Interferon, gamma)IBA 03/2006 - 03/2003
2	Peptides (Polypeptides)IBA 11/2022 - 10/2020
2	3-hydroxypyridin-4-oneIBA 01/2021 - 01/2019
2	Neuraminidase (Sialidase)IBA 10/2020 - 01/2016
2	GlycolipidsIBA 11/2019 - 01/2018
2	LipidsIBA 11/2019 - 07/2008
2	Immunoglobulin G (IgG)IBA 11/2019 - 01/2016
2	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 03/2007
2	Respiratory Syncytial Virus VaccinesIBA 01/2019 - 01/2019
2	LipopolysaccharidesIBA 09/2015 - 03/2009
2	bis(3',5')-cyclic diguanylic acidIBA 09/2011 - 09/2009
2	NADP (NADPH)IBA 05/2011 - 03/2009
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 03/2009 - 12/2004
2	Messenger RNA (mRNA)IBA 05/2008 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2007 - 06/2004
2	FibrinIBA 07/2005 - 03/2003
1	Indicators and Reagents (Reagents)IBA 12/2022
1	Heme (Haem)IBA 11/2021
1	InterferonsIBA 08/2021
1	GlycopeptidesIBA 10/2020
1	human ERBB2 proteinIBA 10/2020
1	Bacterial LysatesIBA 08/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Subunit VaccinesIBA 01/2020
1	EmulsionsIBA 11/2019
1	SqualeneIBA 11/2019
1	Vaccine AdjuvantsIBA 11/2019
1	MucinsIBA 11/2019
1	Chelating AgentsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	IronIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2019
1	Chemokine CCL5IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ChitosanIBA 01/2019
1	SirtuinsIBA 01/2017
1	Viral AntigensIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	GinsenosidesIBA 09/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Imipenem FDA Link 08/2013
1	Tigecycline (Tygacil)FDA Link 08/2013
1	Immunologic Factors (Immunomodulators)IBA 09/2011
1	AllergensIBA 01/2011
1	GpGpIBA 09/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2008
1	Monocyte Chemoattractant ProteinsIBA 12/2007
1	Monoclonal AntibodiesIBA 12/2007

Therapy/Procedure

1	Intranasal Administration 01/2021
1	Oral Administration 01/2019
1	Therapeutics 01/2019
1	Catheters 01/2019